Muscle StrengthPOWER-UPNCT06430879
Performance Output With Haptics - Evaluating Athlete Response and Unrealized Potential
A study testing VICTORY PATCH in people with Muscle Strength and Muscle Weakness, run by SuperPatch Limited LLC at 1 site in United States.
Trial summary
This minimal risk, randomized, double-blind, placebo controlled Institutional Review Board (IRB)-approved observational study with functional measurements, will evaluate athletic performance after use of a drug- free, non-invasive patch (VICTORY Patch; The Super Patch Company Inc.); using KangaTech, Catapult and Force… Read more about this study
- Who is it for?
- Ages 18 to 30 yearsHealthy volunteers can take part
- Conditions the study is for
- Muscle Strength, Muscle Weakness
- What is being tested?
- VICTORY PATCH
- Type of treatment
- Medical device
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 100 participants
- Where
- 1 siteUnited States
- Study dates
- 10 Jul 2024to 1 Nov 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 30 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Adults 18 to 30, inclusive
- Able to provide written informed consent
- Have received a VICTORY Patch if in treatment group.
- Is an athlete on a University of Arizona Varsity Athletic Team
- Agree to having physical activity objectively measured for physical activity, as well as attendance, and participation in intervention.
- Agree to place an adhesive patch on their skin, as instructed, based on selection group.
Who cannot join
- Use of drugs of abuse (illicit or prescription)
- Have an implanted device, or wears, or adheres any electrical device to the body during the study, other than a hearing aid.
- Any current medical or musculoskeletal injury that would prohibit athletic participation
- Any significant injuries in the last month prior to the intervention that may impact tested performance measures.
- New injuries that occur during the course of study testing that may impact performance measures.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: POWER-UP Trial (Performance Output With Haptics - Evaluating Athlete Response and Unrealized Potential)
This minimal risk, randomized, double-blind, placebo controlled Institutional Review Board (IRB)-approved observational study with functional measurements, will evaluate athletic performance after use of a drug- free, non-invasive patch (VICTORY Patch; The Super Patch Company Inc.); using KangaTech, Catapult and Force Plates along with crossover control of trials within the same subject group not receiving an 'active' patch.
Read the detailed description
Emerging technologies that use haptic (skin pressure) technology have been studied and have shown positive improvements in stress levels, balance, sleep, and pain. The VICTORY patch (SuperPatch Company, Toronto, Canada) that also incorporates this technology has shown anecdotal promise to improve athlete performance. With the tools currently in use at the University of Arizona, team coaches and physicians can measure the true impact of neuromuscular changes suggested by the VICTORY patch. This study will measure quadriceps and hamstring strength in isolation as well as peak output in jumping and speed testing within in season training programs with and without VICTORY patch use. When combined with new methods of assessing individual muscle strength (KangaTech) and Force plate as well as Catapult measurements of compound movements of the investigational muscles, the investigators can evaluate the true performance and changes in football athletes with the SuperPatch technology.
- Conditions
- Muscle Strength, Muscle Weakness
- Being tested
- VICTORY PATCH, Sham Patch without VTT
- Keywords
- muscle, quadriceps, hamstrings, college athletes, elite athletes, haptic technology, vibrotactile trigger technology, VTT, neuromuscular changes
- Medical subject headings
- Muscle Weakness
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
VICTORY PATCHDevice
Also called Haptic Vibrotactile Trigger Technology, VTT
Drug- free, non-invasive patch (VICTORY Patch) with haptic vibrotactile trigger technology (VTT)
Sham Patch without VTTDevice
Also called Sham Comparator
Sham Patch without haptic vibrotactile trigger technology (VTT)
| Study group | Role | What they receive |
|---|---|---|
| Active/Treatment | Active comparator | Data will be collected for athletes prior to first use of patch and then 2-3 days later with the active patch (VICTORY PATCH). Follow-up functional measurements will also be taken at 7 and 9-10 days after baseline with second crossover patch use 9-10 days post-baseline. Receives: Device: VICTORY PATCH |
| Non-Active/Control | Sham comparator | Data will be collected for athletes prior to first use of patch and then 2-3 days later with the inactive patch. Follow-up functional measurements will also be taken at 7 and 9-10 days after baseline with second crossover patch use 9-10 days post-baseline. Receives: Device: Sham Patch without VTT |
| Crossover | Other | Data will be collected for athletes prior to first use of patch and then 2-3 days later with the active or inactive patch. Follow-up functional measurements will also be taken at 7 and 9-10 days after baseline with second crossover patch use 9-10 days post-baseline. Receives: Device: VICTORY PATCH; Device: Sham Patch without VTT |
What is being measured
The primary outcome is the main question the study is designed to answer.
Changes in subject performance and strength and intensity/interference scores among and between the treated group and the control group for the athlete.
Evaluation of change in quadriceps and hamstring function via KangaTech measurements (mm/Kg)
Measured: 10 days
Changes in subject performance and strength and intensity/interference scores among and between the treated group and the control group for the athlete.
Evaluation of change in max power of the Ground Reaction Force (GRF) in quadriceps and hamstring function measured by the Vald force plate (F = m * a ; 1 m/s2).
Measured: 10 days
Changes in subject performance and strength and intensity/interference scores among and between the treated group and the control group for the athlete.
Evaluation of of Catapult Global Positioning System (GPS) and change in quadriceps and hamstring function to capture maximum acceleration and maximum speed (meters per second (m/s)) during their field workout.
Measured: 10 days
Changes in subject performance and strength and intensity/interference scores among and between the treated group and the control group for the athlete.
Evaluation of change in subject response to The Borg Rating of Perceived Exertion (RPE) (scale= 1- 10)
Measured: 10 days
Changes in performance based on patch location or playing position with the VICTORY Patch treatment.
Evaluation of performance (overall scores) based on concentration of patch placement among study subjects on either dominant medial forearm or dominant side, or mid-anterior thigh.
Measured: 10 days
Secondary outcomes (1)
Identification of subject phenotype(s) that will have the optimal response to treatment with the VICTORY Patch, as well as athletes having the least positive response.
Evaluation of predictive baseline metrics of playing position and predictive modeling will be used to identify subject phenotype(s) with an optimal, and a least positive, response. The data used as inputs to construct the predictive models will be a collection of the survey results collected from patients at day 0. Optimal and least positive responses will be defined based on changes in performance and other functional measurement scores, and changes in concomitant medications used, in the treatment group between survey dates.
Measured: 10 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 May 2024
- Study start10 Jul 2024
- Primary completion1 Nov 2024
- Study completion1 Nov 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Muscle StrengthStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- Randomized, double-blind, placebo controlled, crossover trial with functional measurements
- Masking
- Triple blind
- Who is masked
- Participant, Care provider, Outcomes assessor
- Enrolment
- 100 participants (actual)
Sponsor and investigators
- Lead sponsor
- SuperPatch Limited LLC
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- University of Arizona, Clarity Science LLC
- Responsible party
- Sponsor
- Investigators
- Mark Sakr, DO, Principal investigator, University of Arizona
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06430879
- Sponsor's protocol ID
- POWER-UP 001
- Acronym
- POWER-UP
- Status last verified
- Dec 2025
- First submitted
- 10 May 2024
- Last updated
- 15 Dec 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 15 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- POWER-UP Trial (Performance Output With Haptics - Evaluating Athlete Response and Unrealized Potential)
- ClinicalTrials.gov ID
- NCT06430879
- Acronym / sponsor ID
- POWER-UP / POWER-UP 001
- Conditions
- Muscle Strength, Muscle Weakness
- Keywords
- muscle, quadriceps, hamstrings, college athletes, elite athletes, haptic technology, vibrotactile trigger technology, VTT
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 100 participants (actual)
- Lead sponsor
- SuperPatch Limited LLCIndustry (pharma, biotech, devices)
- Collaborators
- University of Arizona, Clarity Science LLC
- Study start
- 10 Jul 2024 (actual)
- Primary completion
- 1 Nov 2024 (actual)
- Study completion
- 1 Nov 2024 (actual)
- First posted
- 28 May 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This minimal risk, randomized, double-blind, placebo controlled Institutional Review Board (IRB)-approved observational study with functional measurements, will evaluate athletic performance after use of a drug- free, non-invasive patch (VICTORY Patch; The Super Patch Company Inc.); using KangaTech, Catapult and Force Plates along with crossover control of trials within the same subject group not receiving an 'active' patch.
Detailed description
Emerging technologies that use haptic (skin pressure) technology have been studied and have shown positive improvements in stress levels, balance, sleep, and pain. The VICTORY patch (SuperPatch Company, Toronto, Canada) that also incorporates this technology has shown anecdotal promise to improve athlete performance. With the tools currently in use at the University of Arizona, team coaches and physicians can measure the true impact of neuromuscular changes suggested by the VICTORY patch. This study will measure quadriceps and hamstring strength in isolation as well as peak output in jumping and speed testing within in season training programs with and without VICTORY patch use. When combined with new methods of assessing individual muscle strength (KangaTech) and Force plate as well as Catapult measurements of compound movements of the investigational muscles, the investigators can evaluate the true performance and changes in football athletes with the SuperPatch technology.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Triple blind (participant, care provider, outcomes assessor)
- Number of arms
- 3
- Model description
- Randomized, double-blind, placebo controlled, crossover trial with functional measurements
| Arm | Type | Receives |
|---|---|---|
| Active/Treatment | Active comparator | Device: VICTORY PATCHData will be collected for athletes prior to first use of patch and then 2-3 days later with the active patch (VICTORY PATCH). Follow-up functional measurements will also be taken at 7 and 9-10 days after baseline with second crossover patch use 9-10 days post-baseline. |
| Non-Active/Control | Sham comparator | Device: Sham Patch without VTTData will be collected for athletes prior to first use of patch and then 2-3 days later with the inactive patch. Follow-up functional measurements will also be taken at 7 and 9-10 days after baseline with second crossover patch use 9-10 days post-baseline. |
| Crossover | Other | Device: VICTORY PATCH, Device: Sham Patch without VTTData will be collected for athletes prior to first use of patch and then 2-3 days later with the active or inactive patch. Follow-up functional measurements will also be taken at 7 and 9-10 days after baseline with second crossover patch use 9-10 days post-baseline. |
Who may qualify
- Ages
- 18 to 30 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (6 listed)
- Adults 18 to 30, inclusive
- Able to provide written informed consent
- Have received a VICTORY Patch if in treatment group.
- Is an athlete on a University of Arizona Varsity Athletic Team
- Agree to having physical activity objectively measured for physical activity, as well as attendance, and participation in intervention.
Key exclusion criteria (5 listed)
- Use of drugs of abuse (illicit or prescription)
- Have an implanted device, or wears, or adheres any electrical device to the body during the study, other than a hearing aid.
- Any current medical or musculoskeletal injury that would prohibit athletic participation
- Any significant injuries in the last month prior to the intervention that may impact tested performance measures.
- New injuries that occur during the course of study testing that may impact performance measures.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| VICTORY PATCHAlso: Haptic Vibrotactile Trigger Technology, VTTDrug- free, non-invasive patch (VICTORY Patch) with haptic vibrotactile trigger technology (VTT) | Device | Active/Treatment, Crossover |
| Sham Patch without VTTAlso: Sham ComparatorSham Patch without haptic vibrotactile trigger technology (VTT) | Device | Crossover, Non-Active/Control |
Primary outcome
Changes in subject performance and strength and intensity/interference scores among and between the treated group and the control group for the athlete.
Time frame: 10 days
Evaluation of change in quadriceps and hamstring function via KangaTech measurements (mm/Kg)
Changes in subject performance and strength and intensity/interference scores among and between the treated group and the control group for the athlete.
Time frame: 10 days
Evaluation of change in max power of the Ground Reaction Force (GRF) in quadriceps and hamstring function measured by the Vald force plate (F = m * a ; 1 m/s2).
Changes in subject performance and strength and intensity/interference scores among and between the treated group and the control group for the athlete.
Time frame: 10 days
Evaluation of of Catapult Global Positioning System (GPS) and change in quadriceps and hamstring function to capture maximum acceleration and maximum speed (meters per second (m/s)) during their field workout.
Changes in subject performance and strength and intensity/interference scores among and between the treated group and the control group for the athlete.
Time frame: 10 days
Evaluation of change in subject response to The Borg Rating of Perceived Exertion (RPE) (scale= 1- 10)
Changes in performance based on patch location or playing position with the VICTORY Patch treatment.
Time frame: 10 days
Evaluation of performance (overall scores) based on concentration of patch placement among study subjects on either dominant medial forearm or dominant side, or mid-anterior thigh.
1 secondary outcome
Identification of subject phenotype(s) that will have the optimal response to treatment with the VICTORY Patch, as well as athletes having the least positive response.
Time frame: 10 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Dec 2025.
- Individual participant dataSharing planned: Undecided
Related trials for Muscle Strength
Active, not recruitingObservational study
Possible Sarcopenia, Sarcopenia, and Functional Status in Patients With Primary Sjögren's Syndrome
Primary Sjögren Syndrome, Sarcopenia
Recruiting
Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial
Healthy Volunteer
Recruiting
Characterization and Longitudinal Monitoring of Muscular Phenotype in Patients Admitted to Intensive Care for Sepsis
Sepsis, Myopathy Critical Illness
Not yet recruiting
Acute Effects of High-Intensity Laser Therapy on Pain, Muscle Stiffness, and Grip Strength in Healthy Adults
Exercise-Induced Muscle Fatigue, Fatigue Recovery
Not yet recruitingObservational study
Muscle MRI Fat Fraction Before Surgery to Predict Strength Recovery After Foot-Drop Surgery in Charcot-Marie-Tooth Disease
Foot Drop, Charcot-Marie-Tooth Disease Type 1A
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mark Sakr, DO principal investigator
University of Arizona
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing VICTORY PATCH in people with Muscle Strength and Muscle Weakness, run by SuperPatch Limited LLC at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Changes in subject performance and strength and intensity/interference scores among and between the treated group and the control group for the athlete. (time frame: 10 days). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Dec 2025.